0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
Navn | Trond Mohn Forskningsstiftelse |
---|---|
Orgnr/født år | 988029327 |
Ant aksjer | |
Omsetning | |
Driftsresultat | |
Egenkapital | |
Ant.eiere |
Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
---|---|---|---|---|
Ingen registrert |
Navn | Via | Ant aksjer | Andel | Egenkapital |
---|---|---|---|---|
Ingen registrert |
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Pe Helse AS | 1,000 | 100.0% | -239 | 158,137 | 1 | |
Pluvia AS | 38,645 | 28.9% | -2,170 | 2,195 | 10 | |
Nhv25 Invest AS | 250 | 25.0% | -230 | 64,125 | 46 | |
Forskningsveien Holding AS | 19,803,364 | 20.0% | -194 | 42,480 | 105 | |
Kgj Partnership Iv AS | 4,700 | 19.2% | -2,272 | -2,484 | 18,113 | 9 |
Apim Therapeutics AS | 300,660 | 18.3% | 0 | -3,463 | 11,037 | 143 |
Prophylix Pharma Holding AS | 94,463 | 15.5% | -10 | 3,039 | 40 | |
Kgj Partnership V AS | 440,000 | 15.1% | 11,242 | 10,483 | 79,249 | 15 |
Prif 2017 AS | 1,450,447 | 13.6% | 247 | 230 | 2,386 | 14 |
Sarsia Seed AS | 63,849 | 12.8% | -402 | 6,831 | 16 | |
Sarsia Fond Iii AS | 2,275,647 | 10.9% | -1,210 | 3,215 | 10 | |
Scale Leap Capital I AS | 460,056 | 10.7% | 0 | -612 | 3,613 | 27 |
Sarsia Seed Fond Ii AS | 35,882,352 | 10.6% | -1,432 | 31,160 | 14 | |
Kgj Partnership Viii AS | 230,000 | 10.4% | 387 | -124 | 23,559 | 29 |
Kgj Partnership Vii AS | 312,000 | 10.1% | 4,575 | 4,170 | 41,648 | 21 |
Ktp Invest AS | 125 | 9.9% | -68 | 83,625 | 15 | |
Kgj Partnership Vi AS | 22,200 | 9.6% | 4,862 | 4,525 | 37,171 | 16 |
Obligo Global Infrastruktur Ii AS | 4,328,303 | 8.2% | -42 | 4,634 | 15 | |
Serendipity Topro Co-Invest Fund AS | 4,601,154 | 5.9% | -3 | 4,597 | 30 | |
Urem Real Estate Fund I AS | 1,110,000 | 5.5% | -2,359 | 80,366 | 105 | |
Ursusrem Atlas AS | 366,842 | 5.3% | -33 | 19,041 | 2 | |
Calluna Pharma Poolco AS | 1,827,054 | 5.2% | 32 | |||
Argentum 2018 AS | 24,699,928 | 4.9% | 695 | 585 | 15,039 | 9 |
Icon Capital Vi AS | 26,460 | 4.4% | 3 | -289 | 9,201 | 59 |
Hadean Capital I AS | 422,765 | 4.3% | -141 | -177 | 1,049 | 31 |
Icon Capital Vii AS | 32,800 | 4.2% | -870 | 30,296 | 89 | |
Icon Capital V AS | 15,600 | 3.4% | -249 | 4,507 | 58 | |
Serendipity Partners Fund AS | 19,462,683 | 3.0% | -578 | 13,947 | 56 | |
Argentum 2022 AS | 726,248 | 2.9% | 265 | 21 | 8,423 | 17 |
Turnstone Private Equity Fund I AS | 106,113 | 1.6% | 0 | -473 | 11,477 | 115 |
Exact Therapeutics AS | 288,500 | 0.9% | 0 | -431 | 380 | 271 |
Prif 2017 AS | 25,000 | 0.2% | 4 | 4 | 41 | 14 |
Epsis AS | 5,418 | 0.1% | 13 | 1 | 12 | 58 |
* Justert for eierandel
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Nhv25 Holding AS
Via Nhv25 Invest AS |
250 | 25.0% | -452 | 49,915 | 1 | |
Forskningsveien Ii AS | 17,625,363 | 20.0% | 11,999 | 8,505 | 50,087 | 1 |
Prophylix AS | 0 | 15.5% | -48 | -1,984 | 1 | |
Ktp Holding AS
Via Ktp Invest AS |
99 | 9.9% | -11 | 84,899 | 1 | |
Serendipity Topro Co-Invest Holding AS | 6 | 5.9% | -3 | 4,538 | 2 | |
Arctic Prosjekt 163 AS | 165 | 5.5% | -8 | 31,844 | 1 | |
Arctic Prosjekt 145 AS | 165 | 5.5% | 1 | |||
Urem Fornebu AS | 165 | 5.5% | 1 | |||
Arctic Prosjekt 108 AS | 4,121 | 5.3% | -2 | 2,256 | 3 | |
Ursusrem Atlas AS | 360,073 | 5.2% | -32 | 18,690 | 2 | |
Caedo Oncology AS | 4,920 | 4.7% | 0 | -527 | 680 | 10 |
Serca Pharmaceuticals AS | 32,883 | 4.6% | 164 | -203 | 751 | 16 |
Ic Services 2 AS | 220 | 4.4% | -3 | 8,068 | 1 | |
Ic Marine AS | 3,521 | 4.2% | -3 | 4,429 | 1 | |
Ic Infra AS | 210 | 4.2% | -3 | 11,570 | 1 | |
Ic Maskin AS | 1,682 | 4.2% | -3 | 3 | 1 | |
Apim Therapeutics AS
Via Sarsia Seed AS |
56,834 | 3.5% | 0 | -655 | 2,086 | 143 |
Ic Sport AS | 33,548 | 3.4% | -2 | 5,142 | 1 | |
Pluvia AS | 4,344 | 3.3% | -244 | 247 | 10 | |
En Hel Hall AS | 211 | 3.0% | -39 | 5,300 | 4 | |
Meditain AS | 3 | 3.0% | -0 | 1 | 1 | |
Meditain Midco AS | 3 | 3.0% | -0 | 1 | 1 | |
Sp Topco 4 AS | 3 | 3.0% | -0 | 1 | 2 | |
Serendipity Bobcat Holding AS | 12 | 3.0% | -2 | 4,108 | 2 | |
Sp Topco 2 AS | 3 | 3.0% | -0 | 1 | 2 | |
Serendipity Topro Holding AS | 3 | 3.0% | -1 | 4,598 | 2 | |
Sp Topco I AS | 12 | 3.0% | -1 | 5,177 | 2 | |
Greenpowerhub AS | 199,137 | 2.9% | 173 | -254 | -163 | 227 |
Sea-Hawk Navigation AS
Via Sarsia Seed AS |
119,138 | 2.7% | 107 | -18 | 6 | 14 |
Calluna Pharma AS | 1,768,851 | 2.4% | 6 | |||
Seasmart AS | 218,075 | 2.3% | 49 | -29 | 69 | 14 |
Trisense AS | 264,789 | 2.3% | 15 | -314 | 460 | 14 |
Enua AS | 7,346 | 2.2% | 251 | -140 | 659 | 7 |
En Hel Hall AS | 149 | 2.1% | -27 | 3,740 | 4 | |
Qbee AS | 129 | 2.1% | 40 | -112 | -29 | 11 |
Pacertool AS | 2,381 | 2.1% | 266 | -676 | -36 | 17 |
Defigo AS | 561 | 2.1% | 310 | -499 | 688 | 27 |
Calluna Pharma Poolco AS | 696,988 | 2.0% | 32 | |||
Movel AS | 15,459 | 1.9% | 425 | -203 | 17 | 24 |
Sonoclear AS | 220,815 | 1.8% | 38 | -116 | 816 | 21 |
Keelspot AS | 71,761 | 1.6% | -18 | 77 | 9 | |
Heimdall Power AS | 355,092 | 1.6% | 368 | -818 | 1,410 | 61 |
Domos AS | 51,514 | 1.3% | 30 | -154 | 273 | 43 |
Seafarm Solutions AS
Via Sarsia Seed AS |
16,832 | 1.3% | 2 | -12 | 18 | 6 |
Tk&H Holding AS | 1,595 | 1.3% | 0 | -1 | 150 | 18 |
Med Storm Innovation AS
Via Sarsia Seed AS |
2,490 | 1.1% | 46 | -47 | 18 | 25 |
Offshore Sensing AS | 54 | 0.9% | 46 | -4 | 121 | 4 |
Prophylix Pharma Holding AS
Via Sarsia Seed AS |
4,975 | 0.8% | -1 | 160 | 40 | |
Vestbylog Invest AS | 76 | 0.8% | -8 | 1,668 | 134 | |
Prophylix Pharma Holding AS
Via Sarsia Seed AS |
4,520 | 0.7% | -0 | 145 | 40 | |
Elekt AS | 22,291 | 0.7% | 524 | -93 | 375 | 33 |
Xsens AS | 3,552 | 0.5% | 87 | -73 | 173 | 14 |
Prophylix Pharma Holding AS
Via Sarsia Seed AS |
2,805 | 0.5% | -0 | 90 | 40 | |
Prophylix Pharma Holding AS
Via Sarsia Seed AS |
2,545 | 0.4% | -0 | 82 | 40 | |
Oncoinvent ASA | 39,333 | 0.2% | 12 | -299 | 111 | 446 |
Cardiomech AS | 196,328 | 0.1% | 0 | -22 | 141 | 92 |
Arctic Prosjekt 108 AS | 83 | 0.1% | -0 | 45 | 3 | |
Calluna Pharma Poolco AS | 26,552 | 0.1% | 32 | |||
Nykode Therapeutics ASA
Via Sarsia Seed AS |
245,819 | 0.1% | 10 | -43 | 132 | 7,455 |
Calluna Pharma AS | 35,884 | 0.0% | 6 | |||
Bergenbio ASA
Via Sarsia Seed AS |
1,034,354 | 0.0% | 0 | -74 | 49 | 14,902 |
Soiltech ASA
Via Sarsia Seed AS |
2,386 | 0.0% | 79 | 15 | 55 | 89 |
Calluna Pharma AS | 22,318 | 0.0% | 6 |
* Justert for eierandel